MTND5P20: A Drug Target / Disease Biomarker (G100873269)

Target Name: MTND5P20

NCBI ID: G100873269

Other Name(s): MT-ND5 pseudogene 20

MTND5P20: A Drug Target / Disease Biomarker

MTND5P20 is a protein that is expressed in the brain and is involved in the regulation of multiple neurotransmitter systems, including dopamine (D2) and serotonin (5-HT). It is a potential drug target (or biomarker) for the treatment of various psychiatric and neurological disorders, including depression, anxiety, and schizophrenia.

MTND5P20 is a transmembrane protein that is expressed in the brain and is involved in the regulation of multiple neurotransmitter systems, including dopamine (D2) and serotonin (5-HT). It is a potential drug target (or biomarker) for the treatment of various psychiatric and neurological disorders, including depression, anxiety, and schizophrenia.

MTND5P20 is a protein that is expressed in the brain and is involved in the regulation of multiple neurotransmitter systems, including dopamine (D2) and serotonin (5-HT). It is a potential drug target (or biomarker) for the treatment of various psychiatric and neurological disorders, including depression, anxiety, and schizophrenia.

MTND5P20 is a protein that is expressed in the brain and is involved in the regulation of multiple neurotransmitter systems, including dopamine (D2) and serotonin (5-HT). It is a potential drug target (or biomarker) for the treatment of various psychiatric and neurological disorders, including depression, anxiety, and schizophrenia.

MTND5P20 is a protein that is expressed in the brain and is involved in the regulation of multiple neurotransmitter systems, including dopamine (D2) and serotonin (5-HT). It is a potential drug target (or biomarker) for the treatment of various psychiatric and neurological disorders, including depression, anxiety, and schizophrenia.

MTND5P20 is a protein that is expressed in the brain and is involved in the regulation of multiple neurotransmitter systems, including dopamine (D2) and serotonin (5-HT). It is a potential drug target (or biomarker) for the treatment of various psychiatric and neurological disorders, including depression, anxiety, and schizophrenia.

MTND5P20 is a protein that is expressed in the brain and is involved in the regulation of multiple neurotransmitter systems, including dopamine (D2) and serotonin (5-HT). It is a potential drug target (or biomarker) for the treatment of various psychiatric and neurological disorders, including depression, anxiety, and schizophrenia.

MTND5P20 is a protein that is expressed in the brain and is involved in the regulation of multiple neurotransmitter systems, including dopamine (D2) and serotonin (5-HT). It is a potential drug target (or biomarker) for the treatment of various psychiatric and neurological disorders, including depression, anxiety, and schizophrenia.

MTND5P20 is a protein that is expressed in the brain and is involved in the regulation of multiple neurotransmitter systems, including dopamine (D2) and serotonin (5-HT). It is a potential drug target (or biomarker) for the treatment of various psychiatric and neurological disorders, including depression, anxiety, and schizophrenia.

MTND5P20 is a protein that is expressed in the brain and is involved in the regulation of multiple neurotransmitter systems, including dopamine (D2) and serotonin (5-HT). It is a potential drug target (or biomarker) for the treatment of various psychiatric and neurological disorders, including depression, anxiety, and schizophrenia.

MTND5P20 is a protein that is expressed in the brain and is involved in the regulation of multiple neurotransmitter systems, including dopamine (D2) and serotonin (5-HT). It is a potential drug target (or biomarker) for the treatment of various psychiatric and neurological disorders, including depression, anxiety, and schizophrenia.

MTND5P20 is a protein that is expressed in the brain and is involved in the regulation of multiple neurotransmitter systems, including dopamine (D2) and serotonin (5-HT). It is a potential drug target (or biomarker) for the treatment of various psychiatric and neurological disorders, including depression, anxiety, and schizophrenia.

MTND5P20 is a protein that is expressed in the brain and is involved in the regulation of multiple neurotransmitter systems, including dopamine (D2) and serotonin (5-HT). It is a potential drug target (or biomarker) for the treatment of various psychiatric and neurological disorders, including depression, anxiety, and schizophrenia.

MTND5P20 is a protein that is expressed in the brain and is involved in the regulation of multiple neurotransmitter systems, including dopamine (D2) and serotonin (5-HT). It is a potential drug target (or biomarker) for the treatment of various psychiatric and neurological disorders, including depression, anxiety, and schizophrenia.

MTND5P20 is a protein that is expressed in the brain and is involved in the regulation of multiple neurotransmitter systems, including dopamine (D2) and serotonin (5-HT). It is a potential drug target (or biomarker) for the treatment of various psychiatric and neurological disorders, including depression, anxiety, and schizophrenia.

MTND5P20 is a protein that is expressed in the brain and is involved in the regulation of multiple neurotransmitter systems, including dopamine (D2) and serotonin (5-HT). It is a potential drug target (or biomarker) for the treatment of various psychiatric and neurological disorders, including depression, anxiety, and schizophrenia.

MTND5P20 is a protein that is expressed in the brain and is involved in the regulation of multiple neurotransmitter systems, including dopamine (D2) and serotonin (5-HT). It is a potential drug target (or biomarker) for the treatment of various psychiatric and neurological disorders, including depression, anxiety, and schizophrenia.

MTND5P20 is a protein that is expressed in the brain and is involved in the regulation of multiple neurotransmitter systems, including dopamine (D2) and serotonin (5-HT). It is a potential drug target (or biomarker) for the treatment of various psychiatric and neurological disorders, including depression, anxiety, and schizophrenia.

MTND5P20 is a protein that is expressed in the brain and is involved in the regulation of multiple neurotransmitter systems, including dopamine (D2) and serotonin (5-HT). It is a potential drug target (or biomarker) for the treatment of various psychiatric and neurological disorders, including depression, anxiety, and schizophrenia.

MTND5P20 is a protein that is expressed in the brain and is involved in the regulation of multiple neurotransmitter systems, including dopamine (D2) and serotonin (5-HT). It is a potential drug target (or biomarker) for the treatment of various psychiatric and neurological disorders, including depression, anxiety, and schizophrenia.

MTND5P20 is a protein that is expressed in the brain and is involved in the regulation of multiple neurotransmitter systems, including dopamine (D2) and serotonin (5-HT). It is a potential drug target (or biomarker) for the treatment of various psychiatric and neurological disorders, including depression, anxiety, and schizophrenia.

MTND5P20 is a protein that is expressed in the brain and is involved in the regulation of multiple neurotransmitter systems, including dopamine (D2) and serotonin (5-HT). It is a potential drug target (or biomarker) for the treatment of various psychiatric and neurological disorders, including depression, anxiety, and schizophrenia.

MTND5P20 is a protein that is expressed in the brain and is involved in the regulation of multiple neurotransmitter systems, including dopamine (D2) and serotonin (5-HT). It is a potential drug target (or biomarker) for the treatment of various psychiatric and neurological disorders, including depression, anxiety, and schizophrenia.

MTND5P20 is a protein that is expressed in the brain and is involved in the regulation of multiple neurotransmitter systems, including dopamine (D2) and serotonin (5-HT). It is a potential drug target (or biomarker) for the treatment of various psychiatric and neurological disorders, including depression, anxiety, and schizophrenia.

MTND5P20 is a protein that is expressed in the brain and is involved in the regulation of multiple neurotransmitter systems, including dopamine (D2) and serotonin (5-HT). It is a

Protein Name: MT-ND5 Pseudogene 20

More Common Targets